Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.2% of adults in Fort Worth have diagnosed diabetes — about even with the U.S. 12% figure. Census population 958,692. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fort Worth clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fort Worth storefront.
Joint Preservation Therapy Solutions in Fort Worth, TX for clinics & physicians. Joint preservation therap… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 20.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 12.2% of adults in Fort Worth have diagnosed diabetes — about even with the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. joint preservation therapy inventory is national; utilization is JH-local.
National Joint Preservation Therapy Solutions notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.2% of adults in Fort Worth have diagnosed diabetes — about even with the U.S. 12% figure. Adult obesity in Fort Worth is 34.6% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy joint preservation therapy elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 12.2% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 12.2% of adults — about even with the U.S. 12% figure. Obesity is 34.6%; arthritis is 20.6%. That is place-level BRFSS modeling, not a clinic census and not a Fort Worth trial.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Fort Worth tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Fort Worth, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fort Worth is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fort Worth — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fort Worth. Useful for joint-program math; still needs a diagnosis and privileging.
No Fort Worth storefront. Joe Bradley is an active practice owner. joint preservation therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.